Complete Up To Date Information about Acarexx .
NADA Number: 141-174 | |
| Proprietary Name |
Acarexx® Acarexx™ |
|---|---|
| Sponsor |
Boehringer Ingelheim Vetmedica, Inc. |
| Sponsor Address |
7009 Albert Pick Road Greensboro, NC 27409 USA |
| Ingredients |
Ivermectin |
| Species |
Cat and kitten, excluding under 4 weeks of age |
| Routes of Administration |
Topical |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
| Patent Number |
4761288 4897269 4937078 |
| Exclusivity |
Granted for the treatment of adult ear mite (Otodectes cynotis) infestations in cats and kittens four weeks of age or older. |
|
Dosage Amount, Indications & Limitations |
524.1195 Ivermectin otic suspension. Specifications: Each tube contains 0.5 milliliter of a 0.01 percent suspension of ivermectin. Conditions of use Amount: Administer the contents of one 0.5-milliliter tube topically into each external ear canal. Indications: For the treatment of adult ear mite (Otodectes cynotis) infestations in cats and kittens 4 weeks of age and older. Effectiveness against eggs and immature stages has not been proven. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |
| Tolerances |
A tolerance is established for 22,23-dihydroavermectin B1a (marker residue) in liver (target tissue) as follows: a. In cattle 100 parts per billion. b. In swine 20 parts per billion. c. In sheep 30 parts per billion. d. In reindeer 15 parts per billion. e. In American bison 15 parts per billion. Muscle residues are not indicative of the safety of other edible tissues. A tolerance is established for 22,23-dihydroavermectin B1a (marker residue) in muscle as follows: a. Swine 20 parts per billion b. Cattle 10 parts per billion |